Abstract
One of the attributes of CSII (continuous subcutaneous insulin infusion) is its ability to tailor prandial insulin delivery to the composition of a meal and anticipated glycemic effects. The dual-wave bolus (DWB) is a tool implemented in contemporary insulin pumps that delivers a combination of an instant insulin bolus followed by a square bolus (SB) infused over several hours. We assessed the effectiveness of DWB in 56 adult patients with type 1 diabetes (T1DM) who were on continuous subcutaneous insulin infusion via insulin pump for at least 2 years. We divided patients into frequent (DWB+, n = 32) and infrequent (DWB−, n = 24) DWB users (>20% vs. <20% of daily bolus dose delivered as SB). CSII implementation resulted in a decrease of adjusted HbA1c level by 0.80% (95% CI 0.67–0.93, P < 0.0001) and adjusted mean glycemia by 18.4 mg/dl (95% CI 15.3–21.4, P < 0.0001) in the whole cohort within the first year of observation. It was sustained in the second year, but without further improvement. Frequent DWB use was associated with male sex (59% vs. 17%, p = 0.001) and shorter duration of T1DM (3.4 vs. 11.3 yrs, p < 0.0001), but not with patients’ age (25.7 vs. 27.0 years, P = 0.6). DWB+ patients improved their HbA1c by 0.45% more (95% CI 0.20–0.71, P = 0.0009) than DWB− individuals. In conclusion, DWB might be a tool potentially helping to improve glycemic control in T1DM adult users of insulin pumps. Male patients and those with a shorter duration of diabetes seem to use it more willingly.
Similar content being viewed by others
References
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986
Retnakaran R, Hochman J, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V, Zinman B (2004) Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care 27:2590–2599
Mann JI, De Leeuw I, Hermansen K, Karamanos B, Karlström B, Katsilambros N, Riccardi G, Rivellese AA, Rizkalla S, Slama G, Toeller M, Uusitupa M, Vessby B, Diabetes and Nutrition Study Group (DNSG) of the European Association (2004) Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14:373–394
Pańkowska E, Szypowska A, Lipka M, Szpotańska M, Błazik M, Groele L (2009) Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes. Pediatr Diabetes 10:298–303
O’Connell MA, Gilbertson HR, Donath SM, Cameron FJ (2008) Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type. Diabetes Care 31:1491–1495
Lee SW, Cao M, Sajid S, Hayes M, Choi L, Rother C, de León R (2004) The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in type 1 diabetes. Diabetes Nutr Metab 17:211–216
Jones SM, Quarry JL, Caldwell-McMillan M, Mauger DT, Gabbay RA (2005) Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system. Diabetes Technol Ther 7:233–240
Unger J (1999) A primary care approach to continuous subcutaneous insulin infusion. Clinical Diabetes 17:113–120
Author information
Authors and Affiliations
Corresponding author
Additional information
Tomasz Klupa and Jan Skupien contributed equally to this work.
Rights and permissions
About this article
Cite this article
Klupa, T., Skupien, J., Cyganek, K. et al. The dual-wave bolus feature in type 1 diabetes adult users of insulin pumps. Acta Diabetol 48, 11–14 (2011). https://doi.org/10.1007/s00592-009-0173-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-009-0173-9